VICTOR M. PEREZ ALVAREZ
**** **** ***** ***** *** 219 Baltimore MD, 21217
acry2j@r.postjobfree.com
Experience
Post-Doctoral Fellow
Johns Hopkins School of Medicine, Pathology Department.
2014-2015 (October to June)
Developing and validating a new LC MS/MS method to determine simultaneously 6 different Tyrosine Kinase Inhibitors in patient’s plasma.
Professional Associate
University of Manitoba Department of Internal Medicine and Pharmacology and Therapeutics
2013 – 2015 (December - April)
Design, synthesis and evaluation of analogs of tamoxifen for the treatment of cholangiocarcinoma.
Research Associate
Department of Chemistry
2012-2013 (March to October)
Synthesis of permanent charged pyridine quaternary ammonium salts’ compounds to tag carbohydrates and their determination using MALDI – TOF mass Spectrometry.
Lecturer, Chemistry 1300.
2012 (September to December )
Teaching of a University Chemistry course for 150 students.
Professor
National Polytechnic Institute (CINVESTAV), Pharmacology Department
1987- 2012 (January –May)
Principal Investigator of a Medicinal Chemistry laboratory, Master’s and PhD students’ supervisor. Teaching Organic chemistry and Pharmacology to postgraduate students
Coordinator of Academic Affairs
2005- 2008 (June – September)
Coordinate all the academic activities of 100 post graduate student and 12 professors of the Pharmacology Department.
Education
National Polytechnic Institute (CINVESTAV)
September 1981 – May 1997
PhD degree: "Pharmacology.", May 1997.
PhD. Studies: “Organic Chemistry” June 1995
Master of Science degree: "Pharmacology". October 1985
Mexico City (Mexico)
National Polytechnic Institute (ENCB)
September 1976 – July 1981
Bachelor degree: "Pharmaceutical and Industrial Chemistry." July 1981
Selected Publications (total of 36 refereed publications)
http://www.ncbi.nlm.nih.gov/pubmed/?term=Perez-Alvarez+v.)
1.Bautista W, Perez-Alvarez V., Burczynski F, Raouf A., Klonisch T, Minuk G. Membrane Potential Differences and GABAA Receptor Expression in Hepatic Tumor and Non-tumor Stem Cells. Can J Physiol Pharmacol. 2014; 92: 85-91
2.Rivera-Guevara C, Pérez-Alvarez V, García-Becerra R, Ordaz-Rosado D,Morales-Ríos MS, Hernández-Gallegos E, Cooney AJ, Bravo-Gómez ME, Larrea F,Camacho J. Genomic action of permanently charged tamoxifen derivatives via estrogen receptor-alpha. Bioorg Med Chem. 2010; 18(15):5593-601.
3.Rivera-Becerril E, Joseph-Nathan P, Pérez-Álvarez VM, Morales-Ríos MS. Synthesis and Biological Evaluation of - and -Debromoflustramine B and its analogues as Selective Butyrylcholinesterase Inhibitors. J Med Chem.51 (17):5271-84, 2008.
4.Fernández-Martínez E., Morales-Ríos Martha S., Pérez- Álvarez V., Muriel P. Immunomodulatory effect of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat. Biochem. Pharmacol.; 68: 1321-9, 2004.
5.Pérez-Alvarez V., Morales-Ríos M. S., Hong E. and Joseph-Nathan P. Synthesis and preliminary cardiovascular evaluation of 3-amino-2-(3 indolyl)propanol and propanoate derivatives. J. Pharm. Pharmacol.; 49:246-252, 1997.
6.Muriel P., Garciapiña T., Pérez-Álvarez V., Mourelle M. Silymarin protect paracetamol induced lipid peroxidation and liver damage. J. Appl. Tox.; 12(6): 439-442, 1992.
7.Mourelle M., Amezcua J.L., Pérez-Alvarez V. Reduction of apparent indicators of liver cirrhosis by arachidonate lipoxygenase inhibitor BW755C. European Journal of Pharmacology; 134: 175180, 1987.
Languages and Technologies
I am fluent in English and Spanish (native tongue)
I can understand, speak, read and write very well in both languages.
I am an experienced user of Microsoft Office package, some common statistics, chemistry draw and HPLC, NMR and Mass spectrometry programs, as Xcalibur package software for e.g.
Additional achievements
Book Chapters
1. Pérez-Alvarez V. “Liver role on drug metabolism.” Current concepts on hepatology; Méndez-Sanchez N. y Uribe M. Eds. Masson Doyma México, S.A. pags 53-62, 2003.
Posters presented in International Meetings: 24
Thesis directed.
PhD Thesis: 5
Master in Science Thesis: 5
Distinctions
Research Professor, Level I
Mexico, CONACYT National Research Council.
Since 1994.-2012
Candidacy for Researcher.
Mexico, CONACYT National Research Council.
1988-1994.
Recipient of five grants by the National Council of Science and Technology of Mexico, CONACYT (1998-2009)